Tue, December 11, 2012
Mon, December 10, 2012
Sun, December 9, 2012
Sat, December 8, 2012
Fri, December 7, 2012
Thu, December 6, 2012
Wed, December 5, 2012
Tue, December 4, 2012
Mon, December 3, 2012
Sun, December 2, 2012
Sat, December 1, 2012
Fri, November 30, 2012
Thu, November 29, 2012
Wed, November 28, 2012
Tue, November 27, 2012
Mon, November 26, 2012
Sun, November 25, 2012
Fri, November 23, 2012
Thu, November 22, 2012
Wed, November 21, 2012
Tue, November 20, 2012
Mon, November 19, 2012
Sat, November 17, 2012
Fri, November 16, 2012
Thu, November 15, 2012

Regeneron Named Biotechnology Company of the Year


  Copy link into your clipboard //health-fitness.news-articles.net/content/2012/ .. ron-named-biotechnology-company-of-the-year.html
  Print publication without navigation Published in Health and Fitness on by Market Wire


Regeneron Named Biotechnology Company of the Year -- TARRYTOWN, N.Y., Nov. 29, 2012 /PRNewswire/ --

TARRYTOWN, N.Y., Nov. 29, 2012 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: [ REGN ]) today announced that it was named "Biotechnology Company of the Year" by Scrip Intelligence at the 8th annual Scrip Awards.

The Award recognizes the biotech firm that has achieved the most in the 12 months between June 1, 2011 and May 31, 2012.  In presenting the award, Scrip said, "Regeneron has been transformed over the past year by the U.S. approval of its first major product. On the back of its highly successful launch, the company expects to become profitable for the first time in 2012."

Leonard S. Schleifer, M.D., Ph.D., President and Chief Executive Officer of Regeneron, said, "We are honored to be recognized by Scrip, a leading industry publication.  This has indeed been a transforming time for Regeneron, as we went from having one approved drug to three, advanced investigational drugs into Phase 3 trials, and created shareholder value that moved Regeneron into the top ranks of the biotechnology industry."

George D. Yancopoulos, M.D., Ph.D., President, Regeneron Laboratories and Chief Scientific Officer, said, "Good science is the foundation of Regeneron and long-term success in the biotechnology industry, and it is gratifying that our investments in science and technology over many years are helping patients."

Robert Terifay, Senior Vice President, Commercial, said, "We thank Scrip for this recognition and, most fundamentally, the patients and physicians who are behind the U.S. market acceptance of EYLEA® (aflibercept) Injection, which is now indicated in the U.S. for two eye diseases and which earlier this week was also approved in the European Union."

Award winners were selected by a 16-member panel of leading pharmaceutical industry executives, consultants, and researchers.  More information about the panel is available here:  [ http://www.scripintelligence.com/awards/judges/ ].

About Regeneron Pharmaceuticals
Regeneron is a fully integrated biopharmaceutical company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron markets three products in the United States, EYLEA® (aflibercept) Injection, ZALTRAP® (ziv-aflibercept) Injection for Intravenous Infusion, and ARCALYST® (rilonacept) Injection for Subcutaneous Use; ZALTRAP is co-commercialized with Sanofi.  Phase 3 studies are in progress with EYLEA in two additional indications and with product candidates sarilumab and REGN727.  Regeneron has active research and development programs in many disease areas, including ophthalmology, inflammation, cancer, and hypercholesterolemia.  Additional information and recent news releases are available on the Regeneron web site at [ www.regeneron.com ].

Contact Information:




Michael Aberman, M.D.                     

Peter Dworkin

Investor Relations                                           

Corporate Communications

914-847-7799                                              

914.847.7640             

[ michael.aberman@regeneron.com ]             

[ peter.dworkin@regeneron.com ]

 

SOURCE Regeneron Pharmaceuticals, Inc.



RELATED LINKS
[ http://www.regeneron.com ]

Publication Contributing Sources

Publication Sponsors
[ Last Sunday ] - Oceanside Rental Gear